Evidence map›Paper›PMID 33978292›Full record

ArticleHuman brain mapping2021

Causal structural covariance network revealing atrophy progression in Alzheimer's disease continuum.

Zhao Qing, Feng Chen, Jiaming Lu, Pin Lv, Weiping Li, Xue Liang, Maoxue Wang, Zhengge Wang, Xin Zhang, Bing Zhang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Human brain mapping, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Zhao QingDepartment of Radiology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.ORCID 0000-0002-9816-3611
Feng ChenDepartment of Radiology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
Jiaming LuDepartment of Radiology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
Pin LvDepartment of Radiology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
Weiping LiDepartment of Radiology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
Xue LiangDepartment of Radiology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
Maoxue WangDepartment of Radiology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
Zhengge WangDepartment of Radiology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
Xin ZhangDepartment of Radiology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
Bing ZhangDepartment of Radiology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.ORCID 0000-0001-7592-1195
Alzheimer's Disease Neuroimaging Initiative
Nanjing Drum Tower Hospital · CNNanjing Brain Hospital · CNAlzheimer’s Disease Neuroimaging Initiative · US

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
CIHRNIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

The structural covariance network (SCN) has provided a perspective on the large-scale brain organization impairment in the Alzheimer's Disease (AD) continuum. However, the successive structural impairment across brain regions, which may underlie the disrupted SCN in the AD continuum, is not well understood. In the current study, we enrolled 446 subjects with AD, mild cognitive impairment (MCI) or normal aging (NA) from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. The SCN as well as a casual SCN (CaSCN) based on Granger causality analysis were applied to the T1-weighted structural magnetic resonance images of the subjects. Compared with that of the NAs, the SCN was disrupted in the MCI and AD subjects, with the hippocampus and left middle temporal lobe being the most impaired nodes, which is in line with previous studies. In contrast, according to the 194 subjects with records on CSF amyloid and Tau, the CaSCN revealed that during AD progression, the CaSCN was enhanced. Specifically, the hippocampus, thalamus, and precuneus/posterior cingulate cortex (PCC) were identified as the core regions in which atrophy originated and could predict atrophy in other brain regions. Taken together, these findings provide a comprehensive view of brain atrophy in the AD continuum and the relationships among the brain atrophy in different regions, which may provide novel insight into the progression of AD.

Indexed as

Disease ProgressionAgedAged, 80 and overAgingAlzheimer DiseaseAtrophyCerebral CortexCognitive DysfunctionFemaleHippocampusHumansMagnetic Resonance ImagingMaleThalamusAlzheimer's diseasegranger causality analysismorphometric MRIprogressionstructural covariance network

Identifiers

PMID33978292
PMCPMC8288084
OpenAlexW3162249549

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.